AIoT Health
Calgary, Alberta, Canada
Overview
AIoT Health is a method of improving healthcare by understanding how the "average" individual in a cohort responds to treatment. Through the delivery of personalised medicine in the future, nuance will be added to our layer of knowledge. Digital technology and Machine Learning are tools that aid in the implementation of Personalized Medicine. Digital technology is powerful in that it can improve healthcare outcomes simply by increasing patient engagement. They are very interested in the ability of biofeedback to improve healthcare outcomes without the need for new procedures or drugs. Portable technology's ability to track longitudinal data points easily opens up new metrics and treatment avenues for continuous improvement in healthcare outcomes.
- Total investments
- 2
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Health Care
- Private Cloud
- Venture Capital
Investment portfolio
- Arcascope
Participated · Seed · Sep 2022
Arcascope is a circadian rhythms technology company led by CEO Olivia Walch that uses signals from wearable devices to offer personalized behavioral recommendations and environmental integrations. The company’s core product is a platform currently accessible through the smartphone app Shift that provides evidence-based guidance to address circadian disruption caused by modern life. Arcascope focuses on solutions for shift workers and their employers and plans to accelerate commercial rollout of that offering. It intends to expand into new application areas as it scales. Arcascope raised $2.85M in Seed funding to support those plans. The company is based in Chantilly, VA.
- SeamlessMD
Participated · Series A · Aug 2020
SeamlessMD is a Toronto-based digital patient engagement platform that delivers digital care plans accessible on smartphones, tablets and computers. Its product provides reminders, interactive education, progress tracking, provider alerts, remote monitoring and analytics to help clinicians engage and monitor patients. The platform is used by UAB, Rush, Atrium Health and dozens of other leading health systems across surgery, oncology and chronic care pathways. The company said it will use the new funds to continue expanding operations and its business reach. At the time of the article SeamlessMD had $7.4M in total funding. SeamlessMD provides a smartphone, tablet and computer platform that helps surgical patients learn what to expect, prepare for surgery and recover safely at home. The platform is personalized to a patient’s type of surgery and hospital care plan and delivers evidence-based education, reminders, video content, progress-tracking tools and feedback for self-management. It also offers healthcare providers and administrators real-time analytics to monitor patients remotely, derive insights about the patient experience and measure organizational performance. Led by CEO Dr. Joshua Liu, the company intends to expand its library of surgery programs, build additional clinical evidence and grow its customer base. SeamlessMD raised $1.1M in seed funding to support those plans.
Team
No current team members are available.